Community vs. facility-based directly observed treatment for tuberculosis in Tanzania's Kilimanjaro Region

International Journal of Tuberculosis and Lung Disease

Volumn 13, Issue 12, 2009, Pages 1524-1529

  Van Den Boogaard, Jossy ^a   Lyimo, R ^b   Irongo, C F ^c   Boeree, M J ^a,d   Schaalma, H ^b,e   Aarnoutse, R E ^a   Kibiki, G S ^b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b KILIMANJARO CHRISTIAN MEDICAL CENTRE   (Tanzania)

^c National TB and Leprosy Programme   (Tanzania)

^d University Lung Centre Dekkerswald   (Netherlands)

^e MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Community DOT; Facility based DOT; Patient centred treatment; Treatment outcome; Tuberculosis

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHILD; COMMUNITY CARE; CONTROLLED STUDY; DISEASE CLASSIFICATION; FEMALE; HEALTH CARE FACILITY; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INFANT; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SHORT COURSE THERAPY; SPUTUM SMEAR; TANZANIA; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTITUBERCULAR AGENTS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; COMMUNITY HEALTH SERVICES; DIRECTLY OBSERVED THERAPY; FEMALE; HIV INFECTIONS; HUMANS; INFANT; MALE; MIDDLE AGED; PATIENT-CENTERED CARE; RETROSPECTIVE STUDIES; SPUTUM; TANZANIA; TREATMENT OUTCOME; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

EID: 74949128066     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. World Health Organization. An expanded DOTS framework for effective tuberculosis control. Stop TB communicable diseases. WHO/CDS/TB/2002.297. Geneva, Switzerland: WHO, 2002.
2. World Health Organization. WHO report 2008. Global tuberculosis control: surveillance, planning and financing. WHO/ HTM/TB/2008.393. Geneva, Switzerland: WHO, 2008.
3. Burman W J, Gallicano K, Peloquin C. Comparative pharmacokinetics and pharmacodynamics of the rifamycin antibacterials. Clin Pharmacokinet 2001; 40: 327-341.
4. Lwilla F, Schellenberg D, Masanja H, et al. Evaluation of efficacy of community-based vs. institutional-based direct observed short-course treatment for the control of tuberculosis in Kilombero district, Tanzania. Trop Med Int Health 2003; 8:204-210.
5. Wandwalo E, Kapalata N, Egwaga S, Morkve O. Effectiveness of community-based directly observed treatment for tuberculosis in an urban setting in Tanzania: a randomized controlled trial. Int J Tuberc Lung Dis 2004; 8: 1248-1254.
6. Wandwalo E, Makundi E, Hasler T, Morkve O. Acceptability of community and health facility-based directly observed treatment of tuberculosis in Tanzanian urban setting. Health Policy 2006; 78: 284-294.
7. Ministry of Health and Social Welfare. Manual of the National Tuberculosis and Leprosy Programme in Tanzania. 5th ed. Dar es Salaam, Tanzania: Ministry of Health and Social Welfare, 2006.
8. Tanzania Sensa. 2002 Population and housing census. Dar es Salaam, Tanzania: Tanzania national website, 2003. http:// www.tanzania.go.tz/census/ tables.htm Accessed March 2009.
9. Adatu F, Odeke R, Mugenyi M, Gargioni G, Schneider E, Maher D. Implementation of the DOTS strategy for tuberculosis control in rural Kiboga District, Uganda, offering patients the option of treatment supervision in the community, 1998-1999. Int J Tuberc Lung Dis 2003; 7 (Suppl 1): S63-S71.
10. Banerjee A, Harries A D, Mphasa N, et al. Evaluation of a unified treatment regimen for all new cases of tuberculosis using guardian-based supervision. Int J Tuberc Lung Dis 2000; 4: 333-339.
11. Wright J, Walley J, Philip A, et al. Direct observation of treatment for tuberculosis: a randomized controlled trial of community health workers versus family members. Trop Med Int Health 2004; 9: 559-565.
12. Singh A A, Parasher D, Shekavat G S, Sahu S, Wares D F, Granich R. Effectiveness of urban community volunteers in directly observed treatment of tuberculosis patients: a field report from Hayana, North India. Int J Tuberc Lung Dis 2004; 8: 800-802.
13. Cavalcante S C, Soares E C C, Pacheco A G F, Chaisson R E, Durovni B, and the DOTS Expansion Team. Community DOT for tuberculosis in a Brazilian favela: comparison with a clinic model. Int J Tuberc Lung Dis 2007; 11: 544-549.
14. Walley J, Khan A M, Newell J, Khan H M. Effectiveness of the direct observation component of DOTS for tuberculosis: a randomized controlled trial in Pakistan. Lancet 2001; 357: 664-669.
15. Davidson H, Smirnoff M, Klein S J, Burdick E. Patient satisfaction with care at directly observed therapy programs for tuberculosis in New York City. Am J Public Health 1999; 89: 1567-1570.
16. Wandwalo E, Robberstad B, Morkve O. Cost and cost-effectiveness of community based and health facility based directly observed treatment of tuberculosis in Dar es Salaam, Tanzania. Cost Eff Resour Alloc 2005; 3: 6.
17. Sinanovic E, Floyd K, Dudley L, Azevedo V, Grant R, Maher D. Cost and cost-effectiveness of community-based care for tuberculosis in Cape Town, South Africa. Int J Tuberc Lung Dis 2003; 7 (Suppl 1): S56-S62.
18. Nganda B, Wang'ombe J, Floyd K, Kangani J. Cost and cost-effectiveness of increased community and primary care facility involvement in tuberculosis care in Machakos District, Kenya. Int J Tuberc Lung Dis 2003; 7 (Suppl 1): S14-S20.
19. Khan M A, Walley J D M, Witter S N, Imran A, Safdar N. Costs and cost-effectiveness of different DOT strategies for the treatment of tuberculosis in Pakistan. Health Policy Plann 2002; 17: 178-186.
20. Floyd K, Wilkinson D, Gilks C. Comparison of cost effectiveness of directly observed treatment (DOT) and conventionally delivered treatment for tuberculosis: experience from rural South Africa. BMJ 1997; 315: 1407-1411.
21. Floyd K, Skeva J, Gausi F, Salaniponi F. Cost and cost-effectiveness of increased community and primary care involvement in tuberculosis care in Lilongwe District, Malawi. Int J Tuberc Lung Dis 2003; 7 (Suppl 1): S29-S37.
22. Moulding T S. Adapting to new international tuberculosis treatment standards with medication monitors and DOT given selectively. Trop Med Int Health 2007; 12: 1302-1308.